Epitomee Medical Ltd (TLV:EPIT)
689.90
+8.10 (1.19%)
Jun 12, 2026, 1:44 PM IDT
Epitomee Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 13.65 | 16.57 | 15.63 | 35.95 | 64.31 |
Short-Term Investments | - | 5.51 | 19.16 | 10.18 | - |
Cash & Short-Term Investments | 13.65 | 22.08 | 34.79 | 46.13 | 64.31 |
Cash Growth | -38.19% | -36.53% | -24.59% | -28.27% | 215.12% |
Other Receivables | 0.17 | 0.21 | 0.17 | 0.18 | 0.39 |
Receivables | 0.17 | 0.21 | 0.17 | 0.18 | 0.39 |
Inventory | 0.47 | 0.02 | - | - | - |
Prepaid Expenses | 0.06 | 0.05 | 0.03 | 0.06 | 0.1 |
Other Current Assets | 0.05 | 0.13 | 0.07 | 0.13 | 0.04 |
Total Current Assets | 14.4 | 22.49 | 35.06 | 46.51 | 64.83 |
Property, Plant & Equipment | 18.32 | 17.43 | 4.93 | 8.42 | 1.13 |
Other Long-Term Assets | 0.39 | 0.29 | 0.27 | 0.28 | 0.06 |
Total Assets | 33.11 | 40.21 | 40.27 | 55.2 | 66.02 |
Accounts Payable | 0.31 | 1.09 | 0.54 | 0.31 | 1.14 |
Accrued Expenses | 0.8 | 0.82 | 0.96 | 1.37 | 0.99 |
Current Portion of Leases | 0.73 | 0.58 | 0.45 | 0.49 | 0.3 |
Other Current Liabilities | 0.47 | 0 | 0 | 0 | 0.02 |
Total Current Liabilities | 2.31 | 2.5 | 1.96 | 2.16 | 2.45 |
Long-Term Leases | 4.83 | 3.76 | 3.51 | 3.6 | 0.28 |
Long-Term Unearned Revenue | - | - | - | 10 | 10 |
Total Liabilities | 7.15 | 6.26 | 5.47 | 15.76 | 12.73 |
Common Stock | 0.82 | 0.82 | 0.81 | 0.81 | 0.81 |
Additional Paid-In Capital | 94.39 | 93.78 | 93.17 | 92.14 | 90.6 |
Retained Earnings | -69.63 | -61.02 | -59.56 | -53.87 | -38.48 |
Comprehensive Income & Other | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 |
Total Common Equity | 25.96 | 33.95 | 34.8 | 39.45 | 53.3 |
Shareholders' Equity | 25.96 | 33.95 | 34.8 | 39.45 | 53.3 |
Total Liabilities & Equity | 33.11 | 40.21 | 40.27 | 55.2 | 66.02 |
Total Debt | 5.57 | 4.35 | 3.96 | 4.08 | 0.58 |
Net Cash (Debt) | 8.08 | 17.73 | 30.83 | 42.05 | 63.73 |
Net Cash Growth | -54.42% | -42.48% | -26.67% | -34.03% | 366.78% |
Net Cash Per Share | 0.27 | 0.60 | 1.04 | 1.43 | 36.24 |
Filing Date Shares Outstanding | 29.84 | 29.58 | 29.52 | 29.46 | 29.23 |
Total Common Shares Outstanding | 29.84 | 29.58 | 29.52 | 29.46 | 29.23 |
Working Capital | 12.09 | 19.99 | 33.1 | 44.34 | 62.38 |
Book Value Per Share | 0.87 | 1.15 | 1.18 | 1.34 | 1.82 |
Tangible Book Value | 25.96 | 33.95 | 34.8 | 39.45 | 53.3 |
Tangible Book Value Per Share | 0.87 | 1.15 | 1.18 | 1.34 | 1.82 |
Machinery | 11.71 | 10.95 | 1.06 | 3.89 | 1.23 |
Leasehold Improvements | 2.84 | 2.73 | 0.18 | 1.18 | 0.16 |